HCV infection should be managed in specialist centres

Por Dusheiko, G
Publicado em 2002

Hepatitis C virus updated.

Por Sherlock, S, Dusheiko, G
Publicado em 1991

Resistance to lamivudine therapy: is there more than meets the eye?

Por Dusheiko, G, Bertoletti, A
Publicado em 2005

Hepatitis C virus.

Por Pereira, C, Lee, C A, Dusheiko, G
Publicado em 1991

The science, economics, and effectiveness of combination therapy for hepatitis C

Por DUSHEIKO, G, BARNES, E, WEBSTER, G, WHALLEY, S
Publicado em 2000

A rational approach to the management of hepatitis C infection.

Por Dusheiko, G. M., Khakoo, S., Soni, P., Grellier, L.
Publicado em 1996

Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major.

Por Wonke, B, Hoffbrand, A V, Brown, D, Dusheiko, G
Publicado em 1990

Viral markers in the treatment of hepatitis B and C.

Por Schmilovitz-Weiss, H, Levy, M, Thompson, N, Dusheiko, G
Publicado em 1993

The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985

Por Yee, T, Griffioen, A, Sabin, C, Dusheiko, G, Lee, C
Publicado em 2000

Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.

Por Dusheiko, G. M., Kew, M. C., Rabson, A. R.
Publicado em 1979

Does delta infection play a part in the pathogenesis of hepatitis B virus related hepatocellular carcinoma?

Por Kew, M C, Dusheiko, G M, Hadziyannis, S J, Patterson, A
Publicado em 1984

Prevalence of hepatitis C in patients with primary antibody deficiency

Por WEBSTER, A D B, BROWN, D, FRANZ, A, DUSHEIKO, G
Publicado em 1996

Expression of the hepatitis B virus genome in chronic hepatitis B carriers and patients with hepatocellular carcinoma.

Por Bowyer, S M, Dusheiko, G M, Schoub, B D, Kew, M C
Publicado em 1987

Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals

Por Khakoo, S, Ling, R, Scott, I, Dodi, A, Harrison, T, Dusheiko, G, Madrigal, J
Publicado em 2000

Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.

Por Dusheiko, G M, Hoofnagle, J H, Cooksley, W G, James, S P, Jones, E A
Publicado em 1983

HLA expression in human hepatocellular carcinoma.

Por Paterson, A. C., Sciot, R., Kew, M. C., Callea, F., Dusheiko, G. M., Desmet, V. J.
Publicado em 1988

Selective Regional Chemotherapy of Unresectable Hepatic Tumours Using Lipiodol

Por Novell, J. R., Dusheiko, G., Markham, N. I., Reddy, K., Dick, R., Hobbs, K. E. F.
Publicado em 1991

Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: the role of different immunosuppressive...

Por Papatheodoridis, G, Barton, S, Andrew, D, Clewley, G, Davies, S, Dhillon, A, Dusheiko, G, Davidson, B, Rolles, K, Burroughs, A
Publicado em 1999

Lymphocyte and macrophage phenotypes in chronic hepatitis C infection. Correlation with disease activity.

Por Khakoo, S. I., Soni, P. N., Savage, K., Brown, D., Dhillon, A. P., Poulter, L. W., Dusheiko, G. M.
Publicado em 1997

Selective Radionuclide Localisation in Primary Liver Tumours

Por Novell, J. R., Green, A. J., Hilson, A. J. W., Dusheiko, G., Dick, R., Hobbs, K. E. F.
Publicado em 1994